Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Effectiveness of Quadrivalent HPV Vaccine in HIV-Infected Youth
NCT05435209Phase 4Completed
- Sponsor
- University of Washington
- Start
- May 2022
- Primary completion
- Oct 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of qHPV vaccine in human papillomavirus infection, sponsored by University of Washington. Started May 2022; status: completed.
02
Drugs
qHPV vaccine
03
Conditions
human papillomavirus infection
Beyond the preview
Go deeper on NCT05435209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05435209.